Nanjing Pharmaceutical Group Company LimitedSSE: 600713

(600713)"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Conversion Results of Convertible Bonds and Share Changes

· Issued by Nanjing Pharmaceutical Group Company Limited via Shanghai Stock Exchange

Filed with SSE · Stock code 600713 · · 2 pages · Chinese

Summary by 6ix AI

Nanjing Pharmaceutical Group Company Limited announced the results of its convertible bond conversions and the resulting changes in share capital. The filing details the cumulative conversion amounts and the number of shares created from these conversions. It also outlines the total amount of convertible bonds that remain unconverted as of the reporting date. The report includes a summary of the company's share capital before and after the conversions.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/600713nanjing-pharmaceutical-group-company-limitedannouncement-on-conversion-results-of-convertible-bonds-and-share-changes

Release

Announcement on Conversion Results of Convertible Bonds and Share Changes

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Nanjing Pharmaceutical Group Company Limited on 6ix

Story so far

Earlier from Nanjing Pharmaceutical

Later from Nanjing Pharmaceutical

All Nanjing Pharmaceutical news releases